X0306 4 2017-05-11 0001099800 Edwards Lifesciences Corp EW 0001438538 Szyman Catherine M. ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Critical Care & Vascular Common Stock 2017-05-11 4 A 0 2725.0000 0.0000 A 46528.1453 D Common Stock 3942.0000 I By Spouse Employee Stock Option (Right to Acquire) 110.2500 2017-05-11 4 A 0 24000.0000 0.0000 A 2018-05-11 2024-05-10 Common Stock 24000.0000 24000.0000 D Performance Rights 2017-05-11 4 A 0 3400.0000 0.0000 A 2020-05-11 Common Stock 3400.0000 3400.0000 D These restricted stock units were granted on May 11, 2017 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. These options were granted on May 11, 2017 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 11, 2017 and scheduled to vest on May 11, 2020. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Award. Ifigenia Protopappas, Attorney-in-fact 2017-05-15